Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
97,406.00
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
97,406.00
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
28.00
21.00
18.00
20.00
23.00
23.00
General and Administration Expenses
23,264.00
22,179.00
20,790.00
20,304.00
19,923.00
19,607.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,00,203.00
82,427.00
71,419.00
68,487.00
66,646.00
67,389.00
Operating Profit (PBDIT) excl Other Income
-2,797.00
5,903.00
4,160.00
-994.00
-1,265.00
1,655.00
Other Income
19,169.00
13,064.00
10,143.00
14,777.00
18,373.00
5,347.00
Operating Profit (PBDIT)
20,887.00
23,634.00
18,414.00
17,743.00
20,701.00
10,001.00
Interest
28.00
21.00
18.00
20.00
23.00
23.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
4,644.00
4,796.00
4,254.00
4,109.00
3,730.00
3,148.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
16,891.00
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
Provision for Tax
2,930.00
3,634.00
3,159.00
3,046.00
3,475.00
2,098.00
Profit After Tax
13,779.00
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
331.53
274.20
246.58
228.30
280.19
113.25
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -147.38% vs 41.90% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 33.33% vs 16.67% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 15.20% vs 7.17% in Mar 2025
Compare Profit and Loss Results of Kissei Pharmaceutical Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
97,406.00
50,370.00
47,036.00
93.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
97,406.00
50,370.00
47,036.00
93.38%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
28.00
465.00
-437.00
-93.98%
General and Administration Expenses
23,264.00
28,265.00
-5,001.00
-17.69%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,00,203.00
47,246.00
52,957.00
112.09%
Operating Profit (PBDIT) excl Other Income
-2,797.00
3,124.00
-5,921.00
-189.53%
Other Income
19,169.00
-290.00
19,459.00
6,710.00%
Operating Profit (PBDIT)
20,887.00
6,181.00
14,706.00
237.92%
Interest
28.00
465.00
-437.00
-93.98%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
4,644.00
3,347.00
1,297.00
38.75%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
16,891.00
1,889.00
15,002.00
794.18%
Provision for Tax
2,930.00
1,363.00
1,567.00
114.97%
Profit After Tax
13,779.00
-805.00
14,584.00
1,811.68%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
331.5267
-5.8974
337.42
5,721.57%
Profit And Loss - Net Sales
Net Sales 97,406.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2,797.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -147.38% vs 41.90% in Mar 2025
Profit And Loss - Interest
Interest 28.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 33.33% vs 16.67% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 13,779.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 15.20% vs 7.17% in Mar 2025






